We are delighted to announce that Dr. Chris Gaj has transitioned to the MedTech team as a Director. In his new role, Dr. Chris will oversee qualitative and quantitative projects for the MedTech team and support, mentor and manage key members of the broader team.
With a background in basic science laboratory research in toxicology, oncology and virology, his experience varies from medical technologies and disposable kits to capital equipment and confocal microscopy. Dr. Chris brings compelling knowledge to the MedTech team, and his reputation as an excellent moderator coupled with his strong quantitative research background is a great fit for our business. His contribution to the MedTech team will help to identify new methods which provide greater value to support our clients’ needs.
Head of the MedTech Division, Sabera Hyderally said of his transition, “I am delighted to welcome Dr. Chris to the MedTech Division. He brings a wealth of experience, deep knowledge and fresh ideas and I’m excited to partner with a researcher of his calibre as we continue our tremendous growth globally.”
Speaking about the transition, CEO Gareth Phillips said, “We are very pleased that Dr. Chris Gaj has joined the MedTech division. He has previously worked with a range of MedTech clients and brings a great depth of experience to the team, which aims to stay at the forefront of best practice and innovation.”
Find out more about our MedTech capabilities »